World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
41718
World Ranking
10321
National Ranking
5308

Bob S. Carter publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bob S. Carter sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 398 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bob S. Carter D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bob S. Carter sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bob S. Carter is affiliated with Harvard University in the United States. Their research spans multiple areas within medicine, biochemistry, genetics, and molecular biology, with a strong focus on neurological and oncological fields. They have produced a significant body of work in molecular biology, genetics, neurology, cancer research, and oncology.

Carter's work covers a variety of specialized topics, including:

  • Glioma Diagnosis and Treatment
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • CAR-T cell therapy research
  • Nanoplatforms for cancer theranostics
  • Cancer Genomics and Diagnostics
  • Single-cell and spatial transcriptomics

The scientist's frequent publication venues reflect their interdisciplinary expertise, with numerous contributions in:

  • Neurosurgery
  • Neuro-Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of neurosurgery
  • Cancers

Bob S. Carter has collaborated extensively with several colleagues, most frequently with Leonora Balaj, William T. Curry, Brian V. Nahed, Daniel P. Cahill, and Anudeep Yekula.

Some of the notable recent papers authored by Carter include:

  • "Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease," 2020, New England Journal of Medicine
  • "Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies," 2020, International Forum of Allergy & Rhinology
  • "Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma," 2024, New England Journal of Medicine
  • "Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression," 2022, Nature Immunology
  • "An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma," 2021, Nature Biomedical Engineering

Best Publications

  • An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

    Cyril Neftel;Julie Laffy;Mariella G. Filbin;Toshiro Hara

  • Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.

    Johnny C. Akers;David Gonda;Ryan Kim;Bob S. Carter

  • Family history and the risk of prostate cancer.

    Gary D. Steinberg;Bob S. Carter;Terri H. Beaty;Barton Childs

  • Mendelian inheritance of familial prostate cancer.

    Bob S. Carter;Terri H. Beaty;Gary D. Steinberg;Barton Childs

  • Hereditary Prostate Cancer: Epidemiologic and Clinical Features

    Bob S. Carter;G. Steven Bova;Terri H. Beaty;Gary D. Steinberg

  • Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

    Umbas R;Schalken Ja;Aalders Tw;Carter Bs

  • Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

    Huilin Shao;Jaehoon Chung;Leonora Balaj;Alain Charest

  • Allelic loss of chromosomes 16q and 10q in human prostate cancer.

    B S Carter;C M Ewing;W S Ward;B F Treiger

  • Sexual function following radical prostatectomy : influence of preservation of neurovascular bundles

    David M. Quinlan;Jonathan I. Epstein;Bob S. Carter;Patrick C. Walsh

  • Microfluidic isolation and transcriptome analysis of serum microvesicles

    Chihchen Chen;Johan Skog;Chia-Hsien Hsu;Ryan T. Lessard

  • Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.

    William B. Isaacs;Bob S. Carter;Charles M. Ewing

  • Recommendations for the Management of Cerebral and Cerebellar Infarction With Swelling A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

    Eelco F. M. Wijdicks;Kevin N. Sheth;Bob S. Carter;David M. Greer

  • Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma.

    Huilin Shao;Jaehoon Chung;Jaehoon Chung;Kyungheon Lee;Leonora Balaj

  • CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

    Bryan D Choi;Xiaoling Yu;Ana P Castano;Amanda A Bouffard

  • Homozygous Deletion and Frequent Allelic Loss of Chromosome 8p22 Loci in Human Prostate Cancer

    G S Bova;B S Carter;B S Carter;B S Carter;M J Bussemakers;M Emi

  • Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles

    Franz L. Ricklefs;Franz L. Ricklefs;Quazim Alayo;Harald Krenzlin;Ahmad B. Mahmoud;Ahmad B. Mahmoud

  • Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.

    Manish K. Aghi;Bob S. Carter;Garth R. Cosgrove;Robert G. Ojemann

  • Coding and noncoding landscape of extracellular RNA released by human glioma stem cells

    Zhiyun Wei;Arsen O. Batagov;Sergio Schinelli;Jintu Wang

  • One-year Outcome after Decompressive Surgery for Massive Nondominant Hemispheric Infarction

    Bob S. Carter;Christopher S. Ogilvy;Guillermo J. Candia;H. Diana Rosas

  • Androgen receptor gene mutations in human prostate cancer.

    Jay R. Newmark;Dianne O. Hardy;Dalal C. Tonb;Bob S. Carter

Frequent Co-Authors

Christopher S. Ogilvy
Christopher S. Ogilvy Beth Israel Deaconess Medical Center
Fred G. Barker
Fred G. Barker Harvard University
Fred H. Hochberg
Fred H. Hochberg Massachusetts General Hospital
Xandra O. Breakefield
Xandra O. Breakefield Harvard University
Santosh Kesari
Santosh Kesari University of California, San Diego
Frank B. Furnari
Frank B. Furnari University of California, San Diego
Richard C. Mulligan
Richard C. Mulligan Harvard University
Anders M. Dale
Anders M. Dale J. Craig Venter Institute
William B. Isaacs
William B. Isaacs Johns Hopkins University
Linda M. Liau
Linda M. Liau University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring medical studies in the USA, there are several online degree and career pathways worth considering. Many students look for flexible options that allow them to advance their careers without disrupting their current schedules.

For registered nurses, rn bsn online programs no clinicals are a convenient choice, as they remove the need for additional clinical hours while still providing advanced knowledge. Licensed practical nurses can accelerate their progress with a 6 month lpn program online, making a career switch or advancement possible in less time.

For those aiming for a terminal nursing degree, options abound as well. If time is a concern, consider the shortest dnp programs, which allow you to earn a Doctor of Nursing Practice efficiently. Alternatively, choose from the easiest dnp programs if you're seeking a supportive learning environment with less stringent entry requirements.

These online pathways can open doors to advanced roles and specialized fields in healthcare, all while balancing work, life, and study.

Best Scientists Citing Bob S. Carter

Trending Scientists

Recently Published Articles